Christopher McCabe, BA (Hons), MSc, PhD
Executive Director and CEOEmail Phone: +1 780 448 4881
Dr. Christopher McCabe is the Executive Director and CEO of the Institute of Health Economics (IHE).
Dr. McCabe brings more than 25 years of experience as an internationally recognized health economist to his role with the organization. He was more recently a Professor of Health Economics at the University of Alberta, where he was appointed Capital Health Endowed Research Chair at the University of Alberta, leading two Genome Canada research groups focused on the evaluation, adoption and implementation of Precision Medicine technologies. He also served on the Canadian Agency for Drugs and Technologies in Health Care (CADTH) Health Economics Working Group, which authored the 4th Edition of the CADTH Guidelines for the Economic Evaluation of Health Technologies earlier this year.
Prior to his work in Canada, Dr. McCabe was appointed to the Chair in Health Economics at the University of Leeds in 2007, and went on to be the Founding Director of the Academic Unit of Health Economics within the Leeds Institute of Health Science. He has also held Chairs in Health Economics at the Universities of Warwick and Sheffield.
Starting in the early 2000’s, Dr. McCabe worked extensively with the U.K.’s National Institute for Health and Care Excellence (NICE); initially as team leader on the technology appraisal of disease modifying drugs for multiple sclerosis and subsequently as the Founding Director of the NICE Decision Support Unit. He was an expert advisor to the 2008 Edition of the NICE Guide to the Methods of Technology Appraisal, and a member of the writing group for the previous edition in 2003. Dr. McCabe also served as a member of the NICE Medical Technologies Advisory Committee. Prior to his work with NICE, Dr. McCabe worked with local commissioners from U.K.’s National Health Service (NHS), evaluating new technologies to inform funding decisions.
Dr. McCabe received his PhD in Health Economics at the University of Sheffield in the U.K.